ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 979,31
0,52%
Dow Jones
40 813,57
-1,30%
DAX
22 631,00
0,44%
Brent Oil
70,495
0,82%
Bitcoin
82 585,65
1,91%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ligand Pharmaceuticals Incorporated (LGND)

  7. Ligand Pharmaceuticals Incorporated (LGND) Actualités

LGND

Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals Incorporated
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LGND
DateHeureSourceTitreSymboleSociété
07/03/202500h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
03/03/202513h00GlobeNewswire Inc.Ligand to Participate in March Investor ConferencesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/02/202513h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/02/202513h00GlobeNewswire Inc.Ligand Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:LGNDLigand Pharmaceuticals Incorporated
25/02/202513h00GlobeNewswire Inc.Ligand Leads $75 Million Royalty Financing in Castle Creek BiosciencesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
13/02/202513h00Business WireLigand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025NASDAQ:LGNDLigand Pharmaceuticals Incorporated
06/02/202513h00Business WireLigand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:LGNDLigand Pharmaceuticals Incorporated
10/12/202415h00Business WireLigand Hosts 2024 Investor and Analyst Day and Introduces 2025 GuidanceNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/11/202422h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
14/11/202421h19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
14/11/202414h00Business WireLigand to Present at Stifel 2024 Healthcare ConferenceNASDAQ:LGNDLigand Pharmaceuticals Incorporated
08/11/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
17/10/202413h30GlobeNewswire Inc.Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial OfficerNASDAQ:LGNDLigand Pharmaceuticals Incorporated
09/07/202422h52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LGNDLigand Pharmaceuticals Incorporated
01/07/202414h00GlobeNewswire Inc.Lifecore Biomedical Announces Cooperation Agreement with 22NWNASDAQ:LGNDLigand Pharmaceuticals Incorporated
03/06/202422h03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LGNDLigand Pharmaceuticals Incorporated
15/05/202420h45Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
14/02/202412h26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LGNDLigand Pharmaceuticals Incorporated
13/02/202421h39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
11/01/202401h30GlobeNewswire Inc.Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy LasofoxifeneNASDAQ:LGNDLigand Pharmaceuticals Incorporated
05/01/202423h40Dow Jones NewsLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection TreatmentNASDAQ:LGNDLigand Pharmaceuticals Incorporated
01/12/202314h20GlobeNewswire Inc.Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 Development of QTORIN™ rapamycin for Microcystic Lymphatic Malformations and Additional High Unmet Need Clinical IndicationsNASDAQ:LGNDLigand Pharmaceuticals Incorporated
28/11/202315h01GlobeNewswire Inc.Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer SymposiumNASDAQ:LGNDLigand Pharmaceuticals Incorporated
10/11/202303h48Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
06/11/202315h00GlobeNewswire Inc.Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete Remission in a Metastatic Breast Cancer Patient Participating in ELAINE-1 TrialNASDAQ:LGNDLigand Pharmaceuticals Incorporated
18/10/202314h00GlobeNewswire Inc.Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026NASDAQ:LGNDLigand Pharmaceuticals Incorporated
02/10/202315h00GlobeNewswire Inc.Sermonix Pharmaceuticals Shares Results of EQUALS 2 Survey on Vaginal and Sexual Health in Patients with ER+/HER2- Metastatic Breast CancerNASDAQ:LGNDLigand Pharmaceuticals Incorporated
26/09/202300h12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
17/07/202314h45GlobeNewswire Inc.Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 ProtectionNASDAQ:LGNDLigand Pharmaceuticals Incorporated
29/06/202315h00GlobeNewswire Inc.Sermonix Pharmaceuticals to Present Two Posters at The Menopause Society 2023 Annual MeetingNASDAQ:LGNDLigand Pharmaceuticals Incorporated
 Showing the most relevant articles for your search:NASDAQ:LGND

Dernières Valeurs Consultées

NASDAQ
CJDPX
Cibc Managed Growth Plus...
NASDAQ
CCWNX
Ci Doubleline Total Retu...
NASDAQ
CJRBX
Counsel Retirement Prese...
NASDAQ
FEAQX
Bmo Retirement Balanced ...
NASDAQ
FEJGX
Bmo Sustainable Balanced...
NASDAQ
DDZSX
Marquis Institutional Gl...
NASDAQ
DAGDX
Chorus Ii Moderate Low V...
UNSW3
PAXETH
PayperEx
NASDAQ
PDAOX
Pgim Target Date 2070 Fu...
NASDAQ
CGXGX
Ci Synergy American Fund...
POLO
LDOUSDT
Lido DAO Token
NASDAQ
CEFPX
Ci Global Shortterm Bond...
NASDAQ
FEFGX
Bmo Selecttrust Equity G...
NASDAQ
CCHDX
Ci Canadian Income and G...
NASDAQ
CJQZX
Counsel Retirement Prese...
NASDAQ
FAXOX
Agf American Growth Fund...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces